Hull University Teaching Hospitals NHS Trust
hey.nhs.ukLive pipeline data from ClinicalTrials.gov, refreshed daily.
Total trials
94
Active
19
Phase 3
4
Total enrollment
123,090
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Monofer | — | — | — | — | — | 1 | |
| Ferrous Sulfate | — | — | — | — | — | 1 | |
| Allergen Specific Immunotherapy | — | — | — | — | — | 1 |
Next readouts
- 2027-05-28
- 2027-10
Top conditions
- Cough8
- Varicose Veins5
- Heart Failure5
- Polycystic Ovary Syndrome3
- Intermittent Claudication3
- COPD3
- Chronic Obstructive Pulmonary Disease2
- Diabetic Foot2
Frequently asked questions about Hull University Teaching Hospitals NHS Trust
- How many clinical trials does Hull University Teaching Hospitals NHS Trust have on ClinicalTrials.gov?
- Hull University Teaching Hospitals NHS Trust is listed as the lead sponsor on 94 clinical trials in ClinicalTrials.gov, 19 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Hull University Teaching Hospitals NHS Trust's trials are in Phase 3?
- 4 of Hull University Teaching Hospitals NHS Trust's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Hull University Teaching Hospitals NHS Trust focus on?
- Hull University Teaching Hospitals NHS Trust's most-studied conditions on ClinicalTrials.gov are Cough, Varicose Veins, Heart Failure, Polycystic Ovary Syndrome, Intermittent Claudication.
- When are Hull University Teaching Hospitals NHS Trust's next clinical trial readouts?
- Hull University Teaching Hospitals NHS Trust has 2 upcoming primary-completion readouts tracked here; the soonest is “Identification of B Regulatory Cells by Flow Cytometry”, expected around 2027-05-28.